ReviewLife (Basel, Switzerland)2026
Environmental Toxic Elements and Atherosclerotic Disease: The Epigenetic Connection.
Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Toxic elements (TEs) are widespread environmental contaminants that act as systemic toxicants and are recognized contributors to atherosclerotic cardiovascular disease (ASCVD) morbidity and mortality, posing significant health risks even at low levels of exposure. Increasing evidence indicates that, beyond their direct genotoxic effects, TEs exert pathogenic actions through epigenetic mechanisms that regulate gene expression without altering the underlying DNA sequence. Major epigenetic modifications associated with TE exposure include aberrant DNA methylation and dysregulation of non-coding RNAs, particularly microRNAs (miRNAs). These modifications may disrupt key vascular cellular processes involved in atherogenesis, including endothelial dysfunction, oxidative stress responses, inflammatory signaling, and lipid metabolism, thereby promoting the initiation and progression of atherosclerotic lesions. The aim of this literature review is to critically examine the evidence linking TE exposure to atherosclerosis, with a particular focus on the potential role of epigenetic mechanisms in mediating this association. Specifically, it summarizes the epidemiological evidence linking TE exposure to ASCVD, discusses the mechanisms through which TE-induced epigenetic alterations may contribute to the development and progression of atherosclerotic disease, and critically evaluates the strengths and limitations of the available evidence to identify priorities for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.